Evidence map›Paper›PMID 40443563›Full record

ArticleThe breast journal2025

Efficacy of Presurgical Short-Term Endocrine Therapy During the Waiting Period for Surgery in Postmenopausal Hormone Receptor-Positive Breast Cancer.

Yuka Maeda, Ayana Sato, Akiko Matsumoto, Tatsuhiko Ikeda, Hiromitsu Jinno

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The breast journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuka MaedaDepartment of Surgery, School of Medicine, Teikyo University, Tokyo, Japan.ORCID 0009-0000-9163-5017
Ayana SatoDepartment of Surgery, School of Medicine, Teikyo University, Tokyo, Japan.ORCID 0000-0002-9402-0437
Akiko MatsumotoDepartment of Surgery, School of Medicine, Teikyo University, Tokyo, Japan.ORCID 0000-0003-0990-0075
Tatsuhiko IkedaDepartment of Surgery, School of Medicine, Teikyo University, Tokyo, Japan.ORCID 0000-0003-3203-7388
Hiromitsu JinnoDepartment of Surgery, School of Medicine, Teikyo University, Tokyo, Japan.ORCID 0000-0002-1331-7053

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Agents, HormonalAromatase InhibitorsBreast NeoplasmsAdultAgedAged, 80 and overErb-b2 Receptor Tyrosine KinasesFemaleHumansKi-67 AntigenMiddle AgedPostmenopausePreoperative CarePrognosisReceptors, EstrogenReceptors, ProgesteroneAntineoplastic Agents, HormonalAromatase InhibitorsErb-b2 Receptor Tyrosine KinasesKi-67 AntigenReceptors, EstrogenReceptors, Progesteronearomatase inhibitorsbreast cancerhormone receptor-positiveneoadjuvant therapy

Identifiers

PMID40443563
PMCPMC12122150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.